Genvoya first TAF-based regimen approved in China for adults and adolescents with HIV
Genvoya first TAF-based regimen approved in China for adults and adolescents with HIV
- China National Drug Administration (CNDA) has approved Genvoya(elvitegravir 150mg/cobicistat 150mg/emtricitabine 200mg/tenofovir ...
- China National Drug Administration (CNDA) has approved Genvoya(elvitegravir 150mg/cobicistat 150mg/emtricitabine 200mg/tenofovir ...